Among the list of mRNAs predicted targets anticorrelated with significantly differentially expressed miRNAs in the chronic stage of epilepsy, of note is the glutamate ionotropic receptor δ type 2 (Grid2), which is anticorrelated with miR-130a-3p, miR-148b-3p, and miR-551b-3p. The gene discussed is GRID2; the disease is epilepsy.